2 years ago
NVAX
AnalystsBrendan SmithBrendan Smith's Stock Forecasts
AnalystsBrendan Smith
Analyst Ranking
Top 27%
#1477 out of 5510 analysts
Average Return
+28.63%
Win Rate
64%9 out of 14
Risk vs Reward
Poor
Good
Brendan Smith's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Twist Bioscience CorpTWST | +266.21% | $34.74 | $127.22 | 2026-01-08 - 2026-09-11 | Strong Buy |
Twist Bioscience CorpTWST | +57.47% | $80.79 | $127.22 | 2026-06-15 - 2026-09-11 | Strong Buy |
Halozyme Therapeutics IncHALO | +48.62% | $72.13 | $107.20 | 2026-01-08 - 2026-09-11 | Strong Buy |
Halozyme Therapeutics IncHALO | +44.94% | $39.81 | $57.70 | 2024-02-29 - 2025-02-27 | Buy |
Ginkgo Bioworks Holdings IncDNA | +41.95% | $8.01 | $11.37 | 2024-09-20 - 2025-09-19 | Strong Buy |
Brendan Smith Analyst Color
Get additional color on Brendan Smith's coverage of popular stocks
Brendan Smith's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Halozyme Therapeutics IncHALO | 4 | Strong Buy | $105.00 | -2.05% | Maintains | a month ago |
Ginkgo Bioworks Holdings IncDNA | 3 | Hold | $9.00 | +33.33% | Downgrades | a month ago |
Biolife Solutions IncBLFS | 1 | Hold | $31.00 | -11.30% | Downgrades | 2 months ago |
Twist Bioscience CorpTWST | 2 | Strong Buy | $89.00 | -30.04% | Maintains | 3 months ago |
Passage Bio IncPASG | 1 | Hold | N/A | N/A | Downgrades | 5 months ago |
Simulations Plus IncSLP | 3 | Hold | $16.00 | -13.14% | Maintains | 5 months ago |
Schrodinger IncSDGR | 1 | Strong Buy | $24.00 | +26.18% | Maintains | 8 months ago |
Cytek Biosciences IncCTKB | 1 | Strong Buy | $5.00 | +8.46% | Maintains | 8 months ago |
Azenta IncAZTA | 1 | Hold | $39.00 | +26.42% | Maintains | 8 months ago |
Novavax IncNVAX | 2 | Hold | $7.00 | -25.69% | Maintains | 10 months ago |
West Pharmaceutical Services IncWST | 1 | Strong Buy | $350.00 | +1.09% | Initiates Coverage On | 10 months ago |
Exscientia PLCEXAI | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Denali Therapeutics IncDNLI | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.